Listed

Enveric Biosciences, Inc.: Form 10-Q for the period ended Mar 31, 2019

Filed with the SEC on May 14, 2019 and accepted by EDGAR at May 14, 2019, 08:07 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-01-01 to 2019-03-31$10.7mus-gaap:Revenues
Cost of revenue3 months2019-01-01 to 2019-03-31$8.5mus-gaap:CostOfRevenue
Gross profit3 months2019-01-01 to 2019-03-31$2.1mus-gaap:GrossProfit
Selling, general and administrative3 months2019-01-01 to 2019-03-31$2.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-01-01 to 2019-03-31−$1.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-01-01 to 2019-03-31$142.6kus-gaap:InterestExpense
Income tax3 months2019-01-01 to 2019-03-31−$31.2kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-01-01 to 2019-03-31−$1.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-01-01 to 2019-03-31−$0.04us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-01-01 to 2019-03-31−$0.04us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-01-01 to 2019-03-3145,185,080 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2019-01-01 to 2019-03-31−$984.1kus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2019-03-31$1.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-03-31$11.5mus-gaap:AssetsCurrent
Total assetsAt period end2019-03-31$30.5mus-gaap:Assets
Current liabilitiesAt period end2019-03-31$14.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-03-31$19.3mus-gaap:Liabilities
Shareholders' equityAt period end2019-03-31$11.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001140361-19-009043. Last ingested by Listed: Nov 14, 2026, 20:02 ET. Listed shows no prices and gives no investment advice.